Saqib Islam
Chief Executive Officer at SPRINGWORKS THERAPEUTICS, INC.
Net worth: 39 M $ as of 30/03/2024
Profile
Mr. Saqib Islam is an Independent Director at ARS Pharmaceuticals, Inc., an Independent Non-Executive Director at Passage Bio, Inc., a Chief Executive Officer & Director at SpringWorks Therapeutics LLC, a Chief Executive Officer & Director at Springworks Therapeutics, Inc. and a Chief Business Officer at ModernaTX, Inc. He is on the Board of Directors at ARS Pharmaceuticals, Inc., Passage Bio, Inc., SpringWorks Therapeutics LLC and Springworks Therapeutics, Inc. Mr. Islam was previously employed as an Independent Director by ARYA Sciences Acquisition Corp.
III, an Independent Director by Silverback Therapeutics, Inc., a Chief Business Officer by Moderna Therapeutics Inc, an Executive VP, Chief Strategy & Portfolio Officer by Alexion Pharmaceuticals, Inc., a Managing Director by Credit Suisse Asset Management LLC, a Managing Director by Morgan Stanley, a Principal by Merrill Lynch & Co., Inc., and a Principal by The Boston Consulting Group, Inc. He received his undergraduate degree from McGill University and a graduate degree from Columbia Law School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 24/03/2024 | 791,271 ( 1.07% ) | 39 M $ | 30/03/2024 | |
| 26/06/2023 | 15,239 ( 0.02% ) | 155 743 $ | 30/03/2024 | |
PASSAGE BIO, INC.
0.01% | 17/03/2024 | 5,000 ( 0.01% ) | 6 750 $ | 30/03/2024 |
Saqib Islam active positions
| Companies | Position | Start |
|---|---|---|
| PASSAGE BIO, INC. | Director/Board Member | 28/03/2019 |
| SPRINGWORKS THERAPEUTICS, INC. | Chief Executive Officer | 31/07/2018 |
| ARS PHARMACEUTICALS, INC. | Director/Board Member | 07/11/2022 |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 08/05/2016 |
SpringWorks Therapeutics LLC
 SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | Chief Executive Officer | 31/07/2018 |
Former positions of Saqib Islam
| Companies | Position | End |
|---|---|---|
| ARYA SCIENCES ACQUISITION III A | Director/Board Member | 31/10/2021 |
| MODERNA, INC. | Corporate Officer/Principal | 31/07/2017 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31/01/2016 |
Credit Suisse Asset Management LLC
 Credit Suisse Asset Management LLC Investment ManagersFinance Founded in 1999, Credit Suisse Asset Management LLC (CSAM) is a registered investment advisor headquartered in New York City. The firm is an indirect wholly-owned subsidiary of Credit Suisse Group AG (NYSE: CS), a publicly owned foreign bank holding company based in Switzerland. | Corporate Officer/Principal | 31/12/2011 |
| ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Saqib Islam
| McGill University | Undergraduate Degree |
| Columbia Law School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| MORGAN STANLEY | Finance |
| MODERNA, INC. | Health Technology |
| PASSAGE BIO, INC. | Health Technology |
| SPRINGWORKS THERAPEUTICS, INC. | Health Technology |
| ARS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Credit Suisse Asset Management LLC
Credit Suisse Asset Management LLC Investment ManagersFinance Founded in 1999, Credit Suisse Asset Management LLC (CSAM) is a registered investment advisor headquartered in New York City. The firm is an indirect wholly-owned subsidiary of Credit Suisse Group AG (NYSE: CS), a publicly owned foreign bank holding company based in Switzerland. | Finance |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Commercial Services |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Health Technology |
| Merrill Lynch & Co., Inc. | Finance |
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson January 4, 2016 and is headquartered in Seattle, WA. | Health Technology |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | Health Technology |
ARYA Sciences Acquisition Corp. III
 ARYA Sciences Acquisition Corp. III Financial ConglomeratesFinance ARYA Sciences Acquisition Corp III is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which it refers to as its initial business combination. It has not yet selected any business combination target. The company was founded by Joseph Edelman, Adam Stone, Michael Altman, and Konstantin Poukalov on March 27, 2020 and is headquartered in New York, NY. | Finance |
- Stock Market
- Insiders
- Saqib Islam
